Joshua Brody

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Joshua Brody
Jan 7, 2025, 14:30 | Dialogues
ASCO24 Updates: Joshua Brody on Epcoritamab Immunotherapy for DLBCL
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Dec 24, 2024, 11:40 | Blog
Joshua Brody: Practice-changing ASH24 updates on Follicular Lymphoma Immunotherapy
Joshua Brody, Director of Lymphoma Immunotherapy Program at The Icahn School of Medicine at Mount…
Nov 29, 2024, 20:13 | Insight
Joshua Brody: Bispecific antibody immunotherapy for lymphoma
Joshua Brody, Director of Lymphoma Immunotherapy Program at The Icahn School of Medicine at Mount…
Oct 13, 2024, 08:06 | Career
Joshua Brody: Great job opportunity for anyone with PharmD
Joshua Brody, Director, Lymphoma Immunotherapy Program, The Icahn School of Medicine at Mount Sinai, shared…
Sep 12, 2024, 09:29 | Blog
Joshua Brody: How to get access to promising new immunotherapy treatments or patients with follicular lymphoma?
Joshua Brody, Director, Lymphoma Immunotherapy Program, The Icahn School of Medicine at Mount Sinai shared a…
Sep 5, 2024, 05:09 | Blog
Joshua Brody: Excited for the CME event on CAR T-cell therapy for lymphoma and CLL at SOHO2024
Joshua Brody shared on LinkedIn: "Excited for the Amps-to-go-up-to-11 at tomorrow's CME event on CAR…
Aug 20, 2024, 05:20 | Dialogues
Low-Grade Lymphomas: Dr. Joshua Brody on Treatments, Strategies, and Innovations
In this episode of OncoDaily interviews, Dr. Joshua Brody, director of the lymphoma immunotherapy program…
Aug 14, 2024, 10:54 | Blog
Joshua Brody: Great Podcast about Bispecific Antibody immunotherapy for aggressive and indolent lymphomas
Joshua Brody, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute, shared on…
Aug 9, 2024, 10:21 | Insight
Immunotherapy with chemo improves survival for aggressive relapsed lymphoma
Joshua Brody, Director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at…
Jul 18, 2024, 00:18 | Insight
Joshua Brody: Impressive potency of chemo-free immunotherapy as 1st-line treatment for lymphoma
Joshua Brody, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute, shared on…
All: 10 Posts: 1 - 100
Special Coverage